Correlation Between Pfizer and Vertex Pharmaceuticals

By analyzing existing cross correlation between Pfizer Inc and Vertex Pharmaceuticals Incorpor, you can compare the effects of market volatilities on Pfizer and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Vertex Pharmaceuticals.

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both Pfizer and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

Diversification Opportunities for Pfizer and Vertex Pharmaceuticals

-0.24
  Correlation Coefficient
Pfizer Inc
Vertex Pharmaceuticals

Very good diversification

The 3 months correlation between Pfizer and Vertex is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Vertex Pharmaceuticals Incorpo in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Pfizer i.e. Pfizer and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pfizer and Vertex Pharmaceuticals

Considering the 30-days investment horizon, Pfizer Inc is expected to under-perform the Vertex Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.21 times less risky than Vertex Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Vertex Pharmaceuticals Incorpor is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  25,228  in Vertex Pharmaceuticals Incorpor on June 9, 2020 and sell it today you would earn a total of  4,364  from holding Vertex Pharmaceuticals Incorpor or generate 17.3% return on investment over 30 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Vertex Pharmaceuticals Incorpo

 Performance (%) 
      Timeline 
Pfizer Inc 
00

Pfizer Risk-Adjusted Performance

Over the last 30 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Pfizer is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Vertex Pharmaceuticals 
88

Vertex Pharmaceuticals Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorpor are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days. In spite of fairly conflicting basic indicators, Vertex Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Vertex Pharmaceuticals Volatility Contrast

 Predicted Return Density 
      Returns 
Check out your portfolio center. Please also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page